Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: Application of CDX2, CK17, MUC1, and MUC2

American Journal of Surgical Pathology

Volumn 29, Issue 3, 2005, Pages 359-367

  Chu, Peiguo G ^a   Schwarz, Roderich E ^b   Lau, Sean K ^a   Yen, Yun ^a   Weiss, Lawrence M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Ampulla of Vater; CDX2; Cholangiocarcinoma; Immunohistochemistry; Keratin 17; Mucins; Pancreatic adenocarcinoma

Indexed keywords

CYTOKERATIN 17; CYTOKERATIN 20; CYTOKERATIN 7; MUCIN 1; MUCIN 2; MUCIN 5AC; TRANSCRIPTION FACTOR CDX2; TUMOR MARKER;

ADRENAL CORTEX CARCINOMA; ARTICLE; BILE DUCT CARCINOMA; BREAST ADENOCARCINOMA; CANCER CLASSIFICATION; COLON ADENOCARCINOMA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; THYROID CARCINOMA; VATER PAPILLA; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; AMPULLA OF VATER; BILE DUCTS, INTRAHEPATIC; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOCARCINOMA; COMMON BILE DUCT NEOPLASMS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MUCINS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 14644440543     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000149708.12335.6a     Document Type: Article

References (25)

1. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an 'intestinal' pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28:839-848.
2. Albores-Saavedra J, Henson DE, Klimstra DS. Atlas of Tumor Pathology: Tumors of Gallbladder, Extrahepatic Bile Ducts, and Ampulla of Vater, 3rd series, fascicle 27. Washington, DC: Armed Force Institute of Pathology, 2000.
3. Chhieng DC, Benson E, Eltoum I, et al. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer. 2003;99:365-371.
4. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403-439.
5. Drummond F, Putt W, Fox M. Cloning and chromosome assignment of the human CDX2 gene. Ann Huam Genet. 1997;61:393-400.
6. Goldstein NS, Bassi D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas: percentage of positivity and distribution is affected by the cut-point threshold. Am J Clin Pathol. 2001;115:695-702.
7. Goldstein NS, Long A, Kuan SF, et al. Colon signet ring cell adenocarcinoma: immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas. Appl Immunohistochem Mol Morphol. 2000;8:183-188.
8. Hanski C, Hofmeier M, Schmitt-Graff A, et al. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol. 1997;182:385-391.
9. Kurzen H, Esposito L, Langbein L, et al. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma. Am J Dermatopathol. 2001;23:501-509.
10. Lau LW, Weiss LM, Chu PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites. Am J Clin Pathol. 2004;122:61-69.
11. Levi E, Klimstra DS, Adsay NV, et al. MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol. 2004;57:456-462.
12. Luttges J, Feyerabend B, Buchelt T, et al. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol. 2002;26:466-471.
13. Luttges J, Zamboni G, Longnecker D, et al. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001;25:942-948.
14. Miettinen M, Nobel MP, Tuma BT, et al. Immunohistochemical mapping of its distribution in human epithelial tumors and its potential applications. Appl Immunohistochem. 1997;5:152-159.
15. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: pattern of expression in normal epithelia, tumor and culture cells. Cell. 1982;31:11-24.
16. Moskaluk CA, Zhang H, Powell SM, et al. CDX2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. 2003;16:913-919.
17. Phillips RW, Frierson HF Jr, Moskaluk CA. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol. 2003;27:1442-1447.
18. Rossi G, Murer B, Cavazza A, et al. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am J Surg Pathol. 2004;28:442-452.
19. Solcia E, Capella C, Kloppel G. Atlas of Tumor Pathology: Tumors of the Pancreas, 3rd series, fascicle 20. Washington, DC: Armed Forces Institute of Pathology, 1997.
20. Troyanovsky SM, Leube RE, Franke WW. Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol. 1992;59:127-137.
21. Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem. 1995;3:99-107.
22. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303-310.
23. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303-310.
24. Yamamoto O, Asahi M. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma. Br J Dermatol. 1999;140:8-16.
25. Zhou H, Schaefer N, Wolff M, et al. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol. 2004;28:875-882.